This inventor holds 1 USPTO granted patent. Top assignees: Centre Leon Berard, Centre National De La Recherche Scientifique, Commissariat a L'energie Atomique Et Aux Energies Alternatives. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 39 
1 out of 5,383 
1 out of 8,833 
Years Active: 2026
Title: Marc Le Borgne: Innovator in Cancer Treatment
Introduction
Marc Le Borgne is a notable inventor based in Poleymieux-Au-Mont-D'orr, France. He has made significant contributions to the field of cancer treatment through his innovative research and development. His work has led to the creation of a patent that addresses critical health challenges.
Latest Patents
Marc Le Borgne holds a patent for "Indole Derivatives and Uses Thereof for Treating a Cancer." This patent represents his commitment to advancing medical science and improving treatment options for cancer patients. With 1 patent to his name, he continues to be a valuable asset in the field of oncology.
Career Highlights
Throughout his career, Marc has worked with esteemed institutions such as Université Claude Bernard Lyon 1 and Institut National de la Santé et de la Recherche Médicale. His experience in these organizations has allowed him to collaborate with leading experts and contribute to groundbreaking research.
Collaborations
Marc has collaborated with notable colleagues, including Alexandre Bancet and Claude Cochet. These partnerships have enriched his work and fostered an environment of innovation and discovery.
Conclusion
Marc Le Borgne's contributions to cancer treatment through his patent and collaborations highlight his dedication to improving healthcare. His work exemplifies the impact of innovation in the medical field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile